Anti-Inflammatory Lipid Mediators in Asthma
NCT03680976
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
The study will not take place at the University of Pittsburgh
Conditions
Asthma
Interventions
DRUG:
CXA-10
DRUG:
Placebo
Sponsor
Sally E. Wenzel MD